GENE.V - Invictus MD Strategies Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.1500
-0.0100 (-6.25%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.1600
Open0.1600
Bid0.1500 x 0
Ask0.1550 x 0
Day's Range0.1500 - 0.1600
52 Week Range0.1250 - 1.5200
Volume153,135
Avg. Volume178,559
Market Cap19.271M
Beta (3Y Monthly)12.27
PE Ratio (TTM)N/A
EPS (TTM)-0.3680
Earnings DateJun 28, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2016-11-17
1y Target Est2.25
  • GlobeNewswire

    INVICTUS PROVIDES UPDATE ON ACREAGE PHARMS LTD. AND AB LABORATORIES INC.

    INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and Chief Operating Officer of Invictus, is pleased to report that the Company’s wholly owned subsidiary Acreage Pharms Ltd. (“Acreage Pharms”) has hired Kris Love as Vice-President of Production effective August 1, 2019. Mr. Love has many years of experience in cannabis production in Canada and already has become an integral asset to the Company’s operation.

  • GlobeNewswire

    INVICTUS AND AUTHENTIC BRANDS GROUP MUTUALLY AGREE TO TERMINATE LICENSE AGREEMENT

    FRA: 8IS2) The Company  and ABG-HMX, LLC (“ABG”) have mutually agreed to an early termination of the license agreement dated June 1, 2018 (the “License Agreement”)  pursuant to an omnibus settlement and termination agreement (the “Termination Agreement”).  The Company continues to focus on increasing shareholder value by providing quality cannabis and oil to meet the demand of sales to the medical and recreational markets.

  • GlobeNewswire

    INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.

    Vancouver, B.C., Oct. 17, 2019 -- Vancouver, BC, October 17, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company.

  • Imagine Owning Invictus MD Strategies (CVE:GENE) And Trying To Stomach The 89% Share Price Drop
    Simply Wall St.

    Imagine Owning Invictus MD Strategies (CVE:GENE) And Trying To Stomach The 89% Share Price Drop

    It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...

  • GlobeNewswire

    INVICTUS ANNOUNCES APPOINTMENT OF INTERIM CEO AND ALTERNATE DIRECTOR

    Vancouver, B.C., Oct. 08, 2019 -- Vancouver, BC, October 8, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces.

  • GlobeNewswire

    INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS

    Vancouver, B.C., Sept. 24, 2019 --   Vancouver, BC, September 24, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the.

  • GlobeNewswire

    INVICTUS ENTERS INTO AGREEMENT TO SELL FUTURE HARVEST DEVELOPMENT LTD.

    FRA: 8IS1) announces that, the Company has agreed to sell the 82.5% issued and outstanding shares (the “Future Harvest Shares”) of Future Harvest Development Ltd. (“Future Harvest”) which are held by the Company’s wholly owned subsidiary Prestige Worldwide Holdings Inc. (“Prestige”) to SL 152 Ventures Ltd. (“SL 152”), a company owned by Mr. Byron Sheppard, a Director, President and CEO of Future Harvest, and whose company holds the remaining 17.5% of Future Harvest.

  • GlobeNewswire

    INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE

    FRA: 8IS2) is pleased to announce that AB Laboratories Inc. (“AB Labs”) a company which is a 50% owned subsidiary of Invictus has received their amended license from Health Canada to include the new 40,000 sq. ft. custom built cultivation facility located near Hamilton, Ontario. As previously announced on June 26, 2019, AB Labs’ facility contains ten identical cultivation rooms capable of producing over 65 crops annually on a tightly controlled weekly production schedule.  Five rooms have been propagated since receiving the amended license on August 30, 2019.  The initial harvest is scheduled for November 1, 2019.  The remaining rooms are expected to be propagated at a rate of one room per week over the next five weeks to ensure a reliable continuous production of cannabis for the recreational and medical markets.

  • GlobeNewswire

    INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS

    Vancouver, B.C., Aug. 30, 2019 -- Vancouver, BC, August 30, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces.

  • GlobeNewswire

    ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL

    FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage"), the Company's wholly-owned subsidiary, has signed a non-binding term sheet (the "Term Sheet") for a secured term loan of up to $6.0 million (the “Loan Amount”) with an interest rate of 10.0% per annum (the “Term Loan”) on drawn amounts with Trichome Financial Corp. ("Trichome Financial"). Invictus has also signed the Term Sheet as a guarantor of the Term Loan.  The funds drawn on the Term Loan will be used for the completion of the 90,000 square foot Phase III cultivation facility near Edson, Alberta, including the purchase of automated processing equipment and the development of the EU-GMP facility with the remainder to be used for general working capital purposes for both Acreage and the Company.

  • Invictus MD Strategies Corp. Opens the Market
    CNW Group

    Invictus MD Strategies Corp. Opens the Market

    Invictus MD Strategies Corp. Opens the Market

  • GlobeNewswire

    ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

    Vancouver, B.C., Aug. 14, 2019 -- Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.

  • GlobeNewswire

    GENE SIMMONS ABDICATES ROLE AS CHIEF EVANGELIST OFFICER FOR INVICTUS

    Vancouver, B.C., Aug. 12, 2019 -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing.

  • GlobeNewswire

    ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY

    Vancouver, Aug. 06, 2019 -- Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.

  • GlobeNewswire

    Invictus announces Annual General Meeting Results

    Vancouver, British Columbia, July 25, 2019 -- Vancouver, BC, July 25, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA:.

  • GlobeNewswire

    Invictus announces Closing of Non-Brokered Private Placement

    Vancouver, British Columbia, July 09, 2019 -- Vancouver, BC, July 9, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire

    Invictus announces Non-Brokered Private Placement

    Vancouver, British Columbia, July 03, 2019 -- Vancouver, BC, July 3, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire

    INVICTUS ANNOUNCES AB VENTURES INC. UPDATE

    FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that AB Ventures Inc. (“AB Ventures”), a company which Invictus is a 25% shareholder, is a late stage applicant to obtain a cultivation license under the Cannabis Act. AB Ventures received the approval to proceed to construction and will submit its evidence package upon completion of such construction.

  • GlobeNewswire

    INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS

    FRA: 8IS2) today reported financial results for the first quarter ended April 30, 2019. “We are pleased with the progress on reducing the cost of Invictus’ operations and the increases to date on the income generation capacity of the Company. Continued focus on increasing capacity and cost reduction is paramount in developing a profitable business,” stated Mr. Trevor Dixon, Chief Executive Officer of Invictus.

  • GlobeNewswire

    INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

    Vancouver, June 26, 2019 -- Vancouver, BC, June 26, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon,.

  • GlobeNewswire

    Invictus announces Annual General Meeting Date

    Vancouver, British Columbia, June 20, 2019 -- Vancouver, BC, June 20, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire

    UPDATE ON ACREAGE PHARMS LTD.

    Vancouver, British Columbia, June 12, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive.

  • GlobeNewswire

    INVICTUS ANNOUNCES APPOINTMENT TO BOARD

    FRA: 8IS2) announced today that Mr. Colin Kinsley has been appointed to the Board of Directors as an independent Director.  Mr. Kinsley previously served on the Board of Directors of the Corporation (the “Board”) from December, 2014 to June, 2017. Mr. Trevor Dixon, the Company’s Chief Executive Officer, said, “The Company is very pleased to have Mr. Kinsley join the Board.

  • A Look At The Intrinsic Value Of Invictus MD Strategies Corp. (CVE:GENE)
    Simply Wall St.

    A Look At The Intrinsic Value Of Invictus MD Strategies Corp. (CVE:GENE)

    Today we will run through one way of estimating the intrinsic value of Invictus MD Strategies Corp. (CVE:GENE) by...

  • GlobeNewswire

    INVICTUS ANNOUNCES EXECUTIVE APPOINTMENT

    Vancouver, June 05, 2019 -- Vancouver, BC, June 5, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today.